Efficacy of palmitoylethanolamide, epilobium and calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III. Archivio Italiano di Urologia e Andrologia, v. 96, n. 2, 27 Jun.2024.